Einloggen
sharewise has been reworked — much stayed, some things are new. Go to the old view
Predictions / BioLine RX Ltd ADR
NV
nvestor 54% hit rate
Started on 2023-09-30 · Closed
Instrument
BioLine RX Ltd ADR
Stuttgart Stock Exchange
Current
0.10 €
+8.60% today
Start price
1.64 €
Target price
1.00 €
+32.4% to target
End price
1.48 €
Performance (%)
-9.76%
Return to target +32.4%
Confidence 50%
Time horizon 2024-09-30
Performance since start
How it ranks
  • #12 Rank 12 of 28 by performance
  • 11 ratings for this instrument performed better
  • No other running rating for this instrument right now
Summary
This prediction ended on 14.10.23 with a price of €1.48. With a performance of -9.76%, the SELL prediction by nvestor was trending in the right direction. nvestor has 50% into this prediction

Investment thesis

Pros and cons by nvestor

For
Against
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
negative Cash Flow expected

Timeline & discussion

Reasoning and updates for this rating

2
The discussion is visible to sharewise members.
2 comments are waiting for you.